N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents

Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen, Kathleen K. Brown, Jeff E. Cobb, Jon L. Collins, W. Wallace Harrington, Mir A. Hashim, Emily A. Hull-Ryde, Istvan Kaldor, Steven A. Kliewer, Debra H. Lake, Lisa M. Leesnitzer, Jürgen M. Lehmann, James M. Lenhard, Lisa A. Orband-Miller, John F. Miller, Robert A. Mook, Stewart A. Noble, William OliverDerek J. Parks, Kelli D. Plunket, Jerzy R. Szewczyk, Timothy M. Willson

Research output: Contribution to journalArticlepeer-review

285 Scopus citations

Fingerprint

Dive into the research topics of 'N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences